Gene · 2982
Papers525
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 525
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Selective vulnerability of cerebral vasculature to NOTCH3 variants in small vessel disease and rescue by phosphodiesterase-5 inhibitor. | Sci Adv | 2026 | 41931622 | PubTator, text mining | PubMed |
| Chaperonin in health and disease. | Mol Biomed | 2026 | 41920440 | PubTator, text mining | PubMed |
| PAH-former: Transfer learning for efficient discovery of pulmonary arterial hypertension-associated genes. | PLoS One | 2026 | 41790620 | PubTator, text mining | PubMed |
| Integrated analysis and validation of metabolism-related genes in lung transplantation-induced cold ischemia/ reperfusion injury. | PeerJ | 2026 | 41769389 | PubTator, text mining | PubMed |
| Integrative RNA-Seq and TCGA-BRCA Analyses Highlight the Role of LINC01133 in Triple-Negative Breast Cancer. | Biomedicines | 2026 | 41751167 | PubTator, text mining | PubMed |
| Moyamoya Vasculopathy and Atypical Moyamoya-like Patterns: Insights into Diagnosis and Therapeutic Implications. | NeuroSci | 2026 | 41718156 | PubTator, text mining | PubMed |
| Molecular and multimodal biomarkers in Moyamoya disease: from pathogenic mechanisms to clinical translation. | Eur J Med Res | 2026 | 41484923 | PubTator, text mining | PubMed |
| Precision medicine in Moyamoya vasculopathy. | Curr Opin Neurol | 2026 | 41355354 | PubTator, text mining | PubMed |
| In Vitro retinal ganglion cell differentiation and enrichment under the scope: do subtypes matter? | Front Cell Dev Biol | 2025 | 41777802 | PubTator, text mining | PubMed |
| Multi-omics research on moyamoya disease: current perspectives and future directions. | Nutr Metab (Lond) | 2025 | 41354962 | PubTator, text mining | PubMed |
| Shared genetic loci connect cardiovascular disease with blood pressure and lipid traits in East Asian populations. | Front Genet | 2025 | 40630117 | PubTator, text mining | PubMed |
| The Impact of Single Nucleotide Polymorphisms and Other Mechanisms on Aspirin Resistance. | Cardiovasc Hematol Disord Drug Targets | 2025 | 40192046 | PubTator, text mining | PubMed |
| The Guanylate Cyclase Soluble Subunit Alpha-1 Deficiency Impairs Angiogenesis in Zebrafishes and Mice: In Vivo and In Vitro Studies. | Mol Neurobiol | 2025 | 39994159 | PubTator, text mining | PubMed |
| Emerging antihypertensive therapies and cardiovascular, kidney, and metabolic outcomes: a Mendelian randomization study. | Eur Heart J Cardiovasc Pharmacother | 2025 | 39963705 | PubTator, text mining | PubMed |
| Lipoprotein(a) and prothrombotic effects: Evidence from a genetic association study. | Eur J Intern Med | 2025 | 39893136 | PubTator, text mining | PubMed |
| Research Progress and Clinical Translation Potential of Coronary Atherosclerosis Diagnostic Markers from a Genomic Perspective. | Genes (Basel) | 2025 | 39858645 | PubTator, text mining | PubMed |
| Soluble Guanylate Cyclase Dysfunction and Nitric Oxide Pathway in Chronic Rhinosinusitis With Nasal Polyps: Predictive Markers for Postoperative Recurrence. | Am J Rhinol Allergy | 2025 | 39473384 | PubTator, text mining | PubMed |
| Prevalence of Systemic Hypertension and the Effects of Cerebral Revascularization in Patients With Moyamoya Disease. | Stroke Vasc Interv Neurol | 2024 | 41584484 | PubTator, text mining | PubMed |
| Integrated single-cell and bulk RNA sequencing identifies POSTN as a potential biomarker and therapeutic target for rheumatoid arthritis. | Gene | 2024 | 39067546 | PubTator, text mining | PubMed |
| The Promoter Polymorphism rs3918226 of the Endothelial Nitric Oxide Synthase Gene as a Novel Susceptibility Marker for Peripheral Artery Disease. | Ann Vasc Surg | 2024 | 39025213 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2982/papers